Commentary

Commentary
Michael Bloch, MD
Commentary
Symptomatic Orthostatic Hypotension Complicating the Management of Chronic Hypertension: A Vexing Clinical Problem With No Easy Solutions
05/01/2024
In this article, Michael J. Bloch, MD, writes about orthostatic hypotension (OH), which is a frequent problem in patients with hypertension, including the approach to diagnosis and management of patients...
05/01/2024
Commentary
Michael J. Bloch, MD
Commentary
Is Acetaminophen Safe for Patients With Hypertension?
04/19/2024
In this commentary, Michael J Bloch, MD, writes about the use of acetaminophen for pain control in patients with hypertension and patients with an increased risk of cardiovascular events, including results...
04/19/2024
Commentary
Michael J. Bloch, MD
Commentary
Telemedicine Management of Hypertension vs Clinic-Based Hypertension Care in the United States
03/07/2024

Michael Bloch, MD; Evan Bloch

Michael Bloch, MD; Evan Bloch ...
In this commentary, Michael J. Bloch, MD, and Evan Bloch discuss the optimal approach to managing patients with hypertension in the United States, including using patients' self-measured blood pressure and...
03/07/2024
Commentary
Michael J. Bloch, MD
Commentary
Determining Whether to Continue Renin-Angiotension System Blockade in Patients With Advanced Kidney Disease
03/05/2024
In this article, Michael J Bloch, MD, discusses the usage of RAS-blocking agents, slowing the progression of end-stage renal disease, and reducing cardiovascular events in patients with advanced kidney...
03/05/2024
Commentary
Michael J. Bloch, MD
Commentary
Semaglutide Reduces Cardiovascular Outcomes in Non-Diabetes Patients With Established Cardiovascular Disease, Obesity
02/09/2024

Michael Bloch, MD; Evan Bloch 

Michael Bloch, MD; Evan Bloch  ...
In this article, Michael Bloch, MD, and Evan Bloch discuss findings from the SELECT trial, including the use of the glucagon-like peptide 1 receptor agonist, semaglutide, to reduce the risk of major...
02/09/2024
Commentary
Michael J. Bloch, MD
Commentary
Aldosterone Synthase Inhibitors as a Therapeutic Option for Patients With Resistant Hypertension
01/28/2024
In this article, Michael J. Bloch, MD, writes about the results of the recently published BrightHTN study, which examined the use of the investigational aldosterone synthase inhibitor baxdrostat in patients...
01/28/2024
editor's note
etoc
editor's note
New Year, New Content Offerings!
01/23/2024

Anthony Calabro, MA

Anthony Calabro, MA
Consultant is excited to introduce two new content offerings that will be regular features in our monthly eTOC: Case Report Insights and Photoclinic Challenges.
01/23/2024
Commentary
Michael J. Bloch, MD
Commentary
Dietary Sodium Reduction Lowered Blood Pressure in Most Middle-Aged to Elderly Adults, Independent of Hypertension Status
01/19/2024

Michael J. Bloch, MD; Evan Bloch

Michael J. Bloch, MD; Evan Bloch ...
In this article, Michael J. Bloch, MD, and Evan Bloch discuss the findings from the CARDIA-SSBP trial, which investigates the blood pressure responses to dietary sodium increase and decrease across a wide...
01/19/2024
Commentary
Thank you
Commentary
Thank You to Our Peer Reviewers!
12/27/2023
Consultant360 thanks each of our peer reviewers for their time and expertise.
12/27/2023